CMPS - The Momentum Letter

Delic Corp.: Ushering Psychedelics Into The Mainstream

Momentum Letter5 years ago5 years ago033 mins

This is venture investing. We’re betting on this team to create value with our capital. The Delic team didn’t just put their hands out and ask for a truck load of cash. They raised just enough to go out and leverage their expertise and bootstrap VALUE for shareholders. Of the 54 millions shares outstanding over 35 million (including the team’s shares) have been locked up. This demonstrates significant commitment to shareholders and self-confidence in their ability to create value.

Sector Overview—Psychedelic Inspired Pharmaceuticals

Momentum Letter5 years ago5 years ago024 mins

In the past two decades, though, the FDA, U.S. Drug Enforcement Administration, and other governments’ regulators have been quietly easing barriers to research, and scientists are once again finding therapeutic uses for the drugs. These findings are leading to increasing numbers of clinical drug trials that could help bring these psychedelics to market as legal pharmaceutical drugs.